Significance of KDM6A mutation in bladder cancer immune escape
Abstract Background Bladder cancer (BC) is the fourth most prevalent neoplasm in men and is associated with high tumour recurrence rates, leading to major treatment challenges. Lysine-specific demethylase 6A (KDM6A) is frequently mutated in several cancer types; however, its effects on tumour progre...
Main Authors: | Xingxing Chen, Xuehua Lin, Guofu Pang, Jian Deng, Qun Xie, Zhengrong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08372-9 |
Similar Items
-
KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1
by: Lei Liu, et al.
Published: (2021-05-01) -
Novel KDM6A splice-site mutation in kabuki syndrome with congenital hydrocephalus: a case report
by: Zhimei Guo, et al.
Published: (2018-12-01) -
Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome
by: Clara Pribadi, et al.
Published: (2020-12-01) -
Depletion of Demethylase KDM6 Enhances Early Neuroectoderm Commitment of Human PSCs
by: Yajing Meng, et al.
Published: (2021-09-01) -
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
by: Angela M Halstead, et al.
Published: (2017-11-01)